diff --git "a/02078fd7-8b65-496e-8b14-79bd27880e01.json" "b/02078fd7-8b65-496e-8b14-79bd27880e01.json" new file mode 100644--- /dev/null +++ "b/02078fd7-8b65-496e-8b14-79bd27880e01.json" @@ -0,0 +1,40 @@ +{ + "interaction_id": "02078fd7-8b65-496e-8b14-79bd27880e01", + "search_results": [ + { + "page_name": "Krystal Biotech - KRYS - Stock Price Today - Zacks", + "page_url": "https://www.zacks.com/stock/quote/KRYS", + "page_snippet": "View Krystal Biotech, Inc KRYS investment & stock information. Get the latest Krystal Biotech, Inc KRYS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.", + "page_result": "\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n\n\n\n\n\n\n\n\n\n \n \n \n \n Krystal Biotech - KRYS - Stock Price Today - Zacks\n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n
\n
\n\n\n\n
\"Zacks\"
\n
\n \"Close\"\n
\n

Is It Time to Buy KRYS?
Shares are down today.

\n

See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

\n
\n
\n

Is It Time to Sell KRYS?
Shares are down today.

\n

See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

\n
\n
\n
\n \n Enter Your Best Email Address\n \n \n
\n \n \n \n \n
\n

No cost, no obligation to buy anything ever. \u00a0|\u00a0 Privacy Policy

\n
\n\n\n
\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Skip to main content
\n
\r\n

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

\r\n\r\n
\r\n
\r\n\n
\n
\n
\n
\"Zacks
\n
    \n
    \n
    \n\n
    \n\n
      \n
    • \n
    • \n
    • Join Now
    • \n
    • \n Sign In\n \n
      \n
      \n \n \n

      Member Sign In

      \n\n
      \n\n \n \n
      \n\n
      \n \n \n
      \n\n
      \n \n What does \"Remember Me\" do?\n
      \n\n\t\t\t\t\t\t\t\t

      Don't Know Your Password?

      \n\n

      \n\n \n
      \n
      \n \n
    • \n
    • Help
    • \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n \"Zacks\n
    \n
    • Join Now
    • \n
    • \n \n \n
      \n
      \n \n \n

      Member Sign In

      \n
      \n \n \n
      \n
      \n \n \n
      \n
      \n \n
      \n

      Don't Know Your Password?

      \n

      \n \n
      \n
      \n \n
    \n
    \n
    \n \n
    \n
    \n
    \n \n
    \n
    \n \n \n \n \n \n
    \n
    \n
    \n
    \n
    \n \n
    \n
    \n
    \n
    \n \n
    \n
    \n
    \n \n \"Zacks\"\n \n
    \n
    \n \n
    \n
    \n
    \n
    \n \n \"Zacks\n \n\n \n
    \n \n \n \n
    \n \n
    \n
    \n \n
    \r\n

    You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

    \r\n\r\n

    If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

    \r\n\r\n

    OK Cancel

    \r\n
    \r\n\n\n\n\n\n\n\n
    \n\n\n\n
    \n Back to top\n
    \n\n\n\n\n\n
    \n\n\n\n
    \n more\n \n
    \n \n\n\n\n\n\n\n
    \n
    \n\n\n
    \n\n
    \n\n \n \n\n
    \n
    \n
    \n

    Krystal Biotech (KRYS)

    \n

    (Real Time Quote from BATS)

    \n
    \n \n \n
    \n
    \n

    $168.79 USD

    \n
    168.79
    \n
    74,762
    \n
    \n

    -1.36 (-0.80%)

    \n
    \n

    Updated Feb 28, 2024 10:48 AM ET

    \n \n
    \n
    \n\n\n

    \n \n

    \n\n
    \n \n \n \n
    \n
    \n Zacks Rank:\n
    \n
    \n
    \n

    This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

    \r\n\r\n

    \n \n \n \n
    Zacks RankDefinitionAnnualized Return
    1Strong Buy24.18%
    2Buy17.85%
    3Hold9.34%
    4Sell5.12%
    5Strong Sell2.62%
    S&P50010.88%

    \r\n\r\n

    Zacks Rank Education - Learn about the Zacks Rank

    \r\n\r\n

    Zacks Rank Home - Zacks Rank resources in one place

    \r\n\r\n

    Zacks Premium - The only way to fully access the Zacks Rank

    \r\n
    \n

    \n 3-Hold of 5     3    

    \n
    \n \n \n
    \n
    \n Style Scores:\n
    \n
    \n
    \n

    The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

    \r\n

    The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

    \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
    Value ScoreA
    Growth ScoreA
    Momentum ScoreA
    VGM ScoreA
    \r\n

    Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

    \r\n

    As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

    \r\n

    Zacks Style Scores Education - Learn more about the Zacks Style Scores

    \r\n \r\n
    \n

    \nF Value | F Growth | A Momentum | F VGM

    \n
    \n\n \n
    \n
    \n Industry Rank:\n
    \n
    \n
    \n

    The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

    \r\n

    An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

    \r\n

    The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.\r\n

    Zacks Rank Education -- Learn more about the Zacks Rank
    \r\n Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank\r\n

    \n

    \nTop 34% (85 out of 250)

    \n

    Industry: Medical - Biomedical and Genetics

    \n
    \n \n \n \n
    \n
    \n\n \n\n
    \n \n \n\n
    \n\n\n
    \n

    Quote Overview

    \n \n\n\n
    \n\n
    \n

    Stock Activity

    \n \n
    \n \n
    Open
    \n
    170.00
    \n
    \n
    \n
    Day Low
    \n
    167.08
    \n \n
    \n
    \n
    Day High
    \n
    173.00
    \n \n
    \n
    \n
    52 Wk Low
    \n
    70.51
    \n \n
    \n
    \n
    52 Wk High
    \n
    173.00
    \n \n
    \n
    \n
    Avg. Volume
    \n
    437,459
    \n \n
    \n
    \n
    Market Cap
    \n
    4.81 B
    \n \n
    \n
    \n
    Dividend
    \n
    0.00 ( 0.00%)
    \n \n
    \n
    \n
    Beta
    \n
    0.76
    \n \n
    \n \n
    \n\n
    \n

    Key Earnings Data

    \n \n \n
    \n \n
    Earnings ESP\n
    \n
    \n

    Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

    \r\n

    The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.\r\n

    \r\n

    Visit the Earnings ESP Center

    \r\n

    See the Full List of Stocks To Beat Earnings

    \n
    \n
    \n
    0.00%
    \n
    \n
    \n
    Most Accurate Est
    \n
    -0.22
    \n \n
    \n
    \n
    Current Qtr Est
    \n
    -0.22
    \n \n
    \n
    \n
    Current Yr Est
    \n
    -0.38
    \n \n
    \n
    \n
    \n Exp Earnings Date\n
    \n
    \n

    This is an estimated date of earnings release. Neither Zacks Investment\n Research, Inc. nor its Information Providers can guarantee the accuracy,\n completeness, timeliness, or correct sequencing of any of the Information on\n the Web site, including, but not limited to Information originated by Zacks\n Investment Research, Inc, licensed by Zacks Investment Research, Inc. from\n Information Providers, or gathered by Zacks Investment Research, Inc. from\n publicly available sources. There may be delays, omissions, or inaccuracies\n in the Information.

    \n
    \n
    \n
    5/13/24
    \n \n
    \n\n\n
    \n
    Prior Year EPS
    \n
    -2.76
    \n \n
    \n
    \n
    Exp EPS Growth (3-5yr)
    \n

    NA

    \n \n
    \n
    \n
    Forward PE
    \n
    NA
    \n \n
    \n
    \n
    PEG Ratio
    \n
    NA
    \n \n
    \n \n
    \n
    \n\n\n\n
    \n \n \n \n\t\t\t \n \n \n
    Medical » Medical - Biomedical and Genetics
    \n \n
    \n \n
    \n\n\n\n\n
    \n

    Research Report for KRYS

    \n
    \n \"\"Snapshot\n
    \n All Zacks’ Analyst Reports »\n
    \n\n\n
    \n

    News for KRYS

    \n \n \n
      \n \n
    \n
      \n \n
    \n
      \n \n
    \n \n
    \n \"Trending\n
    \n \n
    \n \n \n\n\n\n
    \n\n\n
    \n
    \n \"Industry\n
    \n \n
    \n \n \n\n\n
    \n
    \n \"Industry\n
    \n
    \n\n \n\n\n \n
    \n\n \n\n
    \n\n\n\n\n
    \n
    \n
    \n\n\n\n
    \n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n\n
    \n\n
    \n \n

    \n Due to inactivity, you will be
    signed out in approximately: \n

    \n \n \n
    \n \n
    \n \n
    \n \n
    \n \n
    \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\"\"\n\n\n\n\n", + "page_last_modified": " Wed, 28 Feb 2024 09:51:05 -0600" + }, + { + "page_name": "Krystal Biotech - KRYS - Stock Price Today - Zacks", + "page_url": "https://www.zacks.com/stock/quote/KRYS", + "page_snippet": "View Krystal Biotech, Inc KRYS investment & stock information. Get the latest Krystal Biotech, Inc KRYS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.", + "page_result": "\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n\n\n\n\n\n\n\n\n\n \n \n \n \n Krystal Biotech - KRYS - Stock Price Today - Zacks\n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n
    \n
    \n\n\n\n
    \"Zacks\"
    \n
    \n \"Close\"\n
    \n

    Is It Time to Buy KRYS?
    Shares are down today.

    \n

    See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

    \n
    \n
    \n

    Is It Time to Sell KRYS?
    Shares are down today.

    \n

    See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

    \n
    \n
    \n
    \n \n Enter Your Best Email Address\n \n \n
    \n \n \n \n \n
    \n

    No cost, no obligation to buy anything ever. \u00a0|\u00a0 Privacy Policy

    \n
    \n\n\n
    \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    Skip to main content
    \n
    \r\n

    We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

    \r\n\r\n
    \r\n
    \r\n\n
    \n
    \n
    \n
    \"Zacks
    \n
      \n
      \n
      \n\n
      \n\n
        \n
      • \n
      • \n
      • Join Now
      • \n
      • \n Sign In\n \n
        \n
        \n \n \n

        Member Sign In

        \n\n
        \n\n \n \n
        \n\n
        \n \n \n
        \n\n
        \n \n What does \"Remember Me\" do?\n
        \n\n\t\t\t\t\t\t\t\t

        Don't Know Your Password?

        \n\n

        \n\n \n
        \n
        \n \n
      • \n
      • Help
      • \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n \"Zacks\n
      \n
      • Join Now
      • \n
      • \n \n \n
        \n
        \n \n \n

        Member Sign In

        \n
        \n \n \n
        \n
        \n \n \n
        \n
        \n \n
        \n

        Don't Know Your Password?

        \n

        \n \n
        \n
        \n \n
      \n
      \n
      \n \n
      \n
      \n
      \n \n
      \n
      \n \n \n \n \n \n
      \n
      \n
      \n
      \n
      \n \n
      \n
      \n
      \n
      \n \n
      \n
      \n
      \n \n \"Zacks\"\n \n
      \n
      \n \n
      \n
      \n
      \n
      \n \n \"Zacks\n \n\n \n
      \n \n \n \n
      \n \n
      \n
      \n \n
      \r\n

      You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

      \r\n\r\n

      If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

      \r\n\r\n

      OK Cancel

      \r\n
      \r\n\n\n\n\n\n\n\n
      \n\n\n\n
      \n Back to top\n
      \n\n\n\n\n\n
      \n\n\n\n
      \n more\n \n
      \n \n\n\n\n\n\n\n
      \n
      \n\n\n
      \n\n
      \n\n \n \n\n
      \n
      \n
      \n

      Krystal Biotech (KRYS)

      \n

      (Real Time Quote from BATS)

      \n
      \n \n \n
      \n
      \n

      $168.79 USD

      \n
      168.79
      \n
      74,762
      \n
      \n

      -1.36 (-0.80%)

      \n
      \n

      Updated Feb 28, 2024 10:48 AM ET

      \n \n
      \n
      \n\n\n

      \n \n

      \n\n
      \n \n \n \n
      \n
      \n Zacks Rank:\n
      \n
      \n
      \n

      This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

      \r\n\r\n

      \n \n \n \n
      Zacks RankDefinitionAnnualized Return
      1Strong Buy24.18%
      2Buy17.85%
      3Hold9.34%
      4Sell5.12%
      5Strong Sell2.62%
      S&P50010.88%

      \r\n\r\n

      Zacks Rank Education - Learn about the Zacks Rank

      \r\n\r\n

      Zacks Rank Home - Zacks Rank resources in one place

      \r\n\r\n

      Zacks Premium - The only way to fully access the Zacks Rank

      \r\n
      \n

      \n 3-Hold of 5     3    

      \n
      \n \n \n
      \n
      \n Style Scores:\n
      \n
      \n
      \n

      The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

      \r\n

      The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

      \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
      Value ScoreA
      Growth ScoreA
      Momentum ScoreA
      VGM ScoreA
      \r\n

      Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

      \r\n

      As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

      \r\n

      Zacks Style Scores Education - Learn more about the Zacks Style Scores

      \r\n \r\n
      \n

      \nF Value | F Growth | A Momentum | F VGM

      \n
      \n\n \n
      \n
      \n Industry Rank:\n
      \n
      \n
      \n

      The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

      \r\n

      An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

      \r\n

      The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.\r\n

      Zacks Rank Education -- Learn more about the Zacks Rank
      \r\n Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank\r\n

      \n

      \nTop 34% (85 out of 250)

      \n

      Industry: Medical - Biomedical and Genetics

      \n
      \n \n \n \n
      \n
      \n\n \n\n
      \n \n \n\n
      \n\n\n
      \n

      Quote Overview

      \n \n\n\n
      \n\n
      \n

      Stock Activity

      \n \n
      \n \n
      Open
      \n
      170.00
      \n
      \n
      \n
      Day Low
      \n
      167.08
      \n \n
      \n
      \n
      Day High
      \n
      173.00
      \n \n
      \n
      \n
      52 Wk Low
      \n
      70.51
      \n \n
      \n
      \n
      52 Wk High
      \n
      173.00
      \n \n
      \n
      \n
      Avg. Volume
      \n
      437,459
      \n \n
      \n
      \n
      Market Cap
      \n
      4.81 B
      \n \n
      \n
      \n
      Dividend
      \n
      0.00 ( 0.00%)
      \n \n
      \n
      \n
      Beta
      \n
      0.76
      \n \n
      \n \n
      \n\n
      \n

      Key Earnings Data

      \n \n \n
      \n \n
      Earnings ESP\n
      \n
      \n

      Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

      \r\n

      The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.\r\n

      \r\n

      Visit the Earnings ESP Center

      \r\n

      See the Full List of Stocks To Beat Earnings

      \n
      \n
      \n
      0.00%
      \n
      \n
      \n
      Most Accurate Est
      \n
      -0.22
      \n \n
      \n
      \n
      Current Qtr Est
      \n
      -0.22
      \n \n
      \n
      \n
      Current Yr Est
      \n
      -0.38
      \n \n
      \n
      \n
      \n Exp Earnings Date\n
      \n
      \n

      This is an estimated date of earnings release. Neither Zacks Investment\n Research, Inc. nor its Information Providers can guarantee the accuracy,\n completeness, timeliness, or correct sequencing of any of the Information on\n the Web site, including, but not limited to Information originated by Zacks\n Investment Research, Inc, licensed by Zacks Investment Research, Inc. from\n Information Providers, or gathered by Zacks Investment Research, Inc. from\n publicly available sources. There may be delays, omissions, or inaccuracies\n in the Information.

      \n
      \n
      \n
      5/13/24
      \n \n
      \n\n\n
      \n
      Prior Year EPS
      \n
      -2.76
      \n \n
      \n
      \n
      Exp EPS Growth (3-5yr)
      \n

      NA

      \n \n
      \n
      \n
      Forward PE
      \n
      NA
      \n \n
      \n
      \n
      PEG Ratio
      \n
      NA
      \n \n
      \n \n
      \n
      \n\n\n\n
      \n \n \n \n\t\t\t \n \n \n
      Medical » Medical - Biomedical and Genetics
      \n \n
      \n \n
      \n\n\n\n\n
      \n

      Research Report for KRYS

      \n
      \n \"\"Snapshot\n
      \n All Zacks’ Analyst Reports »\n
      \n\n\n
      \n

      News for KRYS

      \n \n \n
        \n \n
      \n
        \n \n
      \n
        \n \n
      \n \n
      \n \"Trending\n
      \n \n
      \n \n \n\n\n\n
      \n\n\n
      \n
      \n \"Industry\n
      \n \n
      \n \n \n\n\n
      \n
      \n \"Industry\n
      \n
      \n\n \n\n\n \n
      \n\n \n\n
      \n\n\n\n\n
      \n
      \n
      \n\n\n\n
      \n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n\n
      \n\n
      \n \n

      \n Due to inactivity, you will be
      signed out in approximately: \n

      \n \n \n
      \n \n
      \n \n
      \n \n
      \n \n
      \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\"\"\n\n\n\n\n", + "page_last_modified": " Wed, 28 Feb 2024 09:51:05 -0600" + }, + { + "page_name": "Krystal Biotech - KRYS - Stock Price Today - Zacks", + "page_url": "https://www.zacks.com/stock/quote/KRYS", + "page_snippet": "View Krystal Biotech, Inc KRYS investment & stock information. Get the latest Krystal Biotech, Inc KRYS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.", + "page_result": "\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n\n\n\n\n\n\n\n\n\n \n \n \n \n Krystal Biotech - KRYS - Stock Price Today - Zacks\n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n
      \n
      \n\n\n\n
      \"Zacks\"
      \n
      \n \"Close\"\n
      \n

      Is It Time to Buy KRYS?
      Shares are down today.

      \n

      See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

      \n
      \n
      \n

      Is It Time to Sell KRYS?
      Shares are down today.

      \n

      See Zacks' latest analysis. Plus, KRYS info will be updated daily in your free Zacks.com Portfolio Tracker.

      \n
      \n
      \n
      \n \n Enter Your Best Email Address\n \n \n
      \n \n \n \n \n
      \n

      No cost, no obligation to buy anything ever. \u00a0|\u00a0 Privacy Policy

      \n
      \n\n\n
      \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
      Skip to main content
      \n
      \r\n

      We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

      \r\n\r\n
      \r\n
      \r\n\n
      \n
      \n
      \n
      \"Zacks
      \n
        \n
        \n
        \n\n
        \n\n
          \n
        • \n
        • \n
        • Join Now
        • \n
        • \n Sign In\n \n
          \n
          \n \n \n

          Member Sign In

          \n\n
          \n\n \n \n
          \n\n
          \n \n \n
          \n\n
          \n \n What does \"Remember Me\" do?\n
          \n\n\t\t\t\t\t\t\t\t

          Don't Know Your Password?

          \n\n

          \n\n \n
          \n
          \n \n
        • \n
        • Help
        • \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \"Zacks\n
        \n
        • Join Now
        • \n
        • \n \n \n
          \n
          \n \n \n

          Member Sign In

          \n
          \n \n \n
          \n
          \n \n \n
          \n
          \n \n
          \n

          Don't Know Your Password?

          \n

          \n \n
          \n
          \n \n
        \n
        \n
        \n \n
        \n
        \n
        \n \n
        \n
        \n \n \n \n \n \n
        \n
        \n
        \n
        \n
        \n \n
        \n
        \n
        \n
        \n \n
        \n
        \n
        \n \n \"Zacks\"\n \n
        \n
        \n \n
        \n
        \n
        \n
        \n \n \"Zacks\n \n\n \n
        \n \n \n \n
        \n \n
        \n
        \n \n
        \r\n

        You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

        \r\n\r\n

        If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

        \r\n\r\n

        OK Cancel

        \r\n
        \r\n\n\n\n\n\n\n\n
        \n\n\n\n
        \n Back to top\n
        \n\n\n\n\n\n
        \n\n\n\n
        \n more\n \n
        \n \n\n\n\n\n\n\n
        \n
        \n\n\n
        \n\n
        \n\n \n \n\n
        \n
        \n
        \n

        Krystal Biotech (KRYS)

        \n

        (Real Time Quote from BATS)

        \n
        \n \n \n
        \n
        \n

        $168.79 USD

        \n
        168.79
        \n
        74,762
        \n
        \n

        -1.36 (-0.80%)

        \n
        \n

        Updated Feb 28, 2024 10:48 AM ET

        \n \n
        \n
        \n\n\n

        \n \n

        \n\n
        \n \n \n \n
        \n
        \n Zacks Rank:\n
        \n
        \n
        \n

        This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

        \r\n\r\n

        \n \n \n \n
        Zacks RankDefinitionAnnualized Return
        1Strong Buy24.18%
        2Buy17.85%
        3Hold9.34%
        4Sell5.12%
        5Strong Sell2.62%
        S&P50010.88%

        \r\n\r\n

        Zacks Rank Education - Learn about the Zacks Rank

        \r\n\r\n

        Zacks Rank Home - Zacks Rank resources in one place

        \r\n\r\n

        Zacks Premium - The only way to fully access the Zacks Rank

        \r\n
        \n

        \n 3-Hold of 5     3    

        \n
        \n \n \n
        \n
        \n Style Scores:\n
        \n
        \n
        \n

        The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

        \r\n

        The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

        \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
        Value ScoreA
        Growth ScoreA
        Momentum ScoreA
        VGM ScoreA
        \r\n

        Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

        \r\n

        As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

        \r\n

        Zacks Style Scores Education - Learn more about the Zacks Style Scores

        \r\n \r\n
        \n

        \nF Value | F Growth | A Momentum | F VGM

        \n
        \n\n \n
        \n
        \n Industry Rank:\n
        \n
        \n
        \n

        The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

        \r\n

        An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

        \r\n

        The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.\r\n

        Zacks Rank Education -- Learn more about the Zacks Rank
        \r\n Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank\r\n

        \n

        \nTop 34% (85 out of 250)

        \n

        Industry: Medical - Biomedical and Genetics

        \n
        \n \n \n \n
        \n
        \n\n \n\n
        \n \n \n\n
        \n\n\n
        \n

        Quote Overview

        \n \n\n\n
        \n\n
        \n

        Stock Activity

        \n \n
        \n \n
        Open
        \n
        170.00
        \n
        \n
        \n
        Day Low
        \n
        167.08
        \n \n
        \n
        \n
        Day High
        \n
        173.00
        \n \n
        \n
        \n
        52 Wk Low
        \n
        70.51
        \n \n
        \n
        \n
        52 Wk High
        \n
        173.00
        \n \n
        \n
        \n
        Avg. Volume
        \n
        437,459
        \n \n
        \n
        \n
        Market Cap
        \n
        4.81 B
        \n \n
        \n
        \n
        Dividend
        \n
        0.00 ( 0.00%)
        \n \n
        \n
        \n
        Beta
        \n
        0.76
        \n \n
        \n \n
        \n\n
        \n

        Key Earnings Data

        \n \n \n
        \n \n
        Earnings ESP\n
        \n
        \n

        Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

        \r\n

        The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.\r\n

        \r\n

        Visit the Earnings ESP Center

        \r\n

        See the Full List of Stocks To Beat Earnings

        \n
        \n
        \n
        0.00%
        \n
        \n
        \n
        Most Accurate Est
        \n
        -0.22
        \n \n
        \n
        \n
        Current Qtr Est
        \n
        -0.22
        \n \n
        \n
        \n
        Current Yr Est
        \n
        -0.38
        \n \n
        \n
        \n
        \n Exp Earnings Date\n
        \n
        \n

        This is an estimated date of earnings release. Neither Zacks Investment\n Research, Inc. nor its Information Providers can guarantee the accuracy,\n completeness, timeliness, or correct sequencing of any of the Information on\n the Web site, including, but not limited to Information originated by Zacks\n Investment Research, Inc, licensed by Zacks Investment Research, Inc. from\n Information Providers, or gathered by Zacks Investment Research, Inc. from\n publicly available sources. There may be delays, omissions, or inaccuracies\n in the Information.

        \n
        \n
        \n
        5/13/24
        \n \n
        \n\n\n
        \n
        Prior Year EPS
        \n
        -2.76
        \n \n
        \n
        \n
        Exp EPS Growth (3-5yr)
        \n

        NA

        \n \n
        \n
        \n
        Forward PE
        \n
        NA
        \n \n
        \n
        \n
        PEG Ratio
        \n
        NA
        \n \n
        \n \n
        \n
        \n\n\n\n
        \n \n \n \n\t\t\t \n \n \n
        Medical » Medical - Biomedical and Genetics
        \n \n
        \n \n
        \n\n\n\n\n
        \n

        Research Report for KRYS

        \n
        \n \"\"Snapshot\n
        \n All Zacks’ Analyst Reports »\n
        \n\n\n
        \n

        News for KRYS

        \n \n \n
          \n \n
        \n
          \n \n
        \n
          \n \n
        \n \n
        \n \"Trending\n
        \n \n
        \n \n \n\n\n\n
        \n\n\n
        \n
        \n \"Industry\n
        \n \n
        \n \n \n\n\n
        \n
        \n \"Industry\n
        \n
        \n\n \n\n\n \n
        \n\n \n\n
        \n\n\n\n\n
        \n
        \n
        \n\n\n\n
        \n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n\n
        \n\n
        \n \n

        \n Due to inactivity, you will be
        signed out in approximately: \n

        \n \n \n
        \n \n
        \n \n
        \n \n
        \n \n
        \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\"\"\n\n\n\n\n", + "page_last_modified": " Wed, 28 Feb 2024 09:51:05 -0600" + }, + { + "page_name": "Krystal Biotech Stock Price | KRYS Stock Quote, News, and History ...", + "page_url": "https://markets.businessinsider.com/stocks/krys-stock", + "page_snippet": "On Wednesday 11/22/2023 the closing price of the Krystal Biotech Inc Registered Shs share was $102.02 on NAS. Compared to the opening price on Wednesday 11/22/2023 on NAS of $102.54, this is a drop of 0.51%. Krystal Biotech Inc Registered Shs's market capitalization is $2.95 B by 28.21 M shares ...On Wednesday 11/22/2023 the closing price of the Krystal Biotech Inc Registered Shs share was $102.02 on NAS. Compared to the opening price on Wednesday 11/22/2023 on NAS of $102.54, this is a drop of 0.51%. Krystal Biotech Inc Registered Shs's market capitalization is $2.95 B by 28.21 M shares outstanding. Compared to the opening price on Wednesday 11/22/2023 on NAS of $102.54, this is a drop of 0.51%. Krystal Biotech Inc Registered Shs's market capitalization is $2.95 B by 28.21 M shares outstanding. ... Prev. Close ... Feb. 04 2021 Mar. 05 2021 ... *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. ... Krystal Biotech, Inc. is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The latest Krystal Biotech stock prices, stock quotes, news, and KRYS history to help you invest and trade smarter. The company's wide-ranging pipeline is based on its proprietary redosable HSV vector. The firm is led by an experienced management team, is fully-integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing and commercialization. Krystal was founded by Krish Krishnan & Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.", + "page_result": "\n\n\n\n\n\n\n\n\n\n\t\n\t\nKrystal Biotech Stock Price | KRYS Stock Quote, News, and History | Markets Insider\n\n\n\n\n\n\n\t\t\n\t\t\n\t\t\n\n\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\n\n\n\n \n\n\n\n\n\n\t\n\t\n\t\n\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t \n\n\t\n\t\t\n\n\t\n\t\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n \n\n\n\n\t\n\t\"\"\n\t\n\n\n\t\n\t\t\n\n\t\n\t\t
        \n\n\t\n\t\n
        \n
        \n
        \n
        \n \n\n\n \n
        \n\n \n\n
        \n
        \n
        \n
        \n \n
        Search markets
        \n
        \n \n \n \n Search icon\n A magnifying glass. It indicates, \"Click to perform a search\".\n \n \n \n \n \n \n
        \n
        \n
        \n
        \n\n
        \n
        \n \n \n \n My Watchlist\n \n \n \n
        \n
        \n \n\n
        \n
        \n\n\n \n\n\n
        \n\n
        \n
        \n
        \n
        \n \n
        Search markets
        \n
        \n \n \n \n Search icon\n A magnifying glass. It indicates, \"Click to perform a search\".\n \n \n \n \n \n \n
        \n
        \n
        \n
        \n\n \n \n \n \n \n \n\n
        \n
        \n
        \n
        \n \n Close icon\n Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.\n \n \n \n
        \n
        \n
        \n\n\t\n\t
        \n\t
        \n\t\t\n\t
        \n\t\n\n\n\n\n\n\t\t\n\n\n\n\n
        \n\t\t\t\t
        \n
        \n\t\t\n
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t
        \n
        \n\n\n
        \n
        \n
        \n
        \n
        \n
        \n

        \n \n \n\n

        \n
        \n 169.21\n \n \n -0.94\n \n \n -0.56%\n \n
        \n
        \n \n 10:50:47 AM\n NAS\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \n
        \n \n
        \n \n\t\t
        \n\n
        \n
        \n
        \n
        \n Plus500. 81% of retail CFD accounts lose money\n
        \n
        \n
        \n
        \n
        \n
        \n \n \n \n \n \n \n \n \n \n \n
        \n News\n \n Analyst Data\n \n Analyst Opinions\n \n Insider Activity\n \n Dividend Calendar\n
        \n
        \n
        \n\n
        \n\t\t\t\t
        \n\t\t\t\t
        \n
        \ufeff
        \n\n\n
        \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\t\t\t\t\t\t\t\t
        \n
        \t\t\t\t\t\t\t\t\t
        \n\n
        \n On Wednesday morning 02/28/2024 the Krystal Biotech Inc Registered Shs share started trading at the price of $170.00.\n\n Compared to the closing price on Tuesday 02/27/2024 on NAS of $170.15, this is a drop of 0.09%.\n\nThere are 28.21 M shares outstanding in Krystal Biotech Inc Registered Shs, which values the company at $4.43 B.
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n
        \n
        \n

        Krystal Biotech Stock Snapshot

        \n
        \n
        \n 56.00\n
        Bid
        \n
        \n
        \n 100.00\n
        Bid Size
        \n
        \n
        \n 71.07\n
        Ask
        \n
        \n
        \n 400.00\n
        Ask Size
        \n
        \n
        \n 2/28/2024\n
        Date
        \n
        \n
        \n 10:50 AM\n
        Time
        \n
        \n
        \n 128,906.00 \n
        Volume
        \n
        \n
        \n 170.15\n
        Prev. Close
        \n
        \n
        \n 170.00\n
        Open
        \n
        \n
        \n 4.43 B\n
        Market Cap
        \n
        \n
        \n 28.21 M\n
        Number of Shares
        \n
        \n
        \n
        \n
        \n
        \n 167.08\n
        Day Low
        \n
        \n
        \n 173.00\n
        Day High
        \n
        \n
        \n
        \n
        \n
        \n
        169.21
        \n
        \n
        \n
        \n
        \n
        \n 70.51\n
        52 Week Low
        \n
        \n
        \n 173.00\n
        52 Week High
        \n
        \n
        \n
        \n
        \n
        \n
        169.21
        \n
        \n
        \n
        \n
        \n
        \n
        \n 0.00\n
        Dividend
        \n
        \n
        \n 318.10\n
        P/E Ratio
        \n
        \n
        \n 83.30\n
        Free Float in %
        \n
        \n
        \n 2.04\n
        EPS 2024
        \n
        \n
        \n 11.20\n
        Book Value per Share
        \n
        \n
        \n 2.81\n
        Cash Flow per Share
        \n
        \n\n
        \n
        \n\n\t\t\t\t\t\t\t\t\t
        \n
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t
        \n
        \n\t\t
        \n\t
        \n\t\t\t

        \n\t\t\t\tKrystal Biotech News\n\t\t\t\t\tMore News\n\t\t\t

        \n\n\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\tGlobeNewswire\n\t\t\t\t\t\t\n\t\t\t\t\t
        \n\t\t\t\t\t

        \n\t\t\t\t\t\tKrystal Biotech to Present at TD Cowen 44th Annual Health Care Conference\n\t\t\t\t\t

        \n\t\t\t\t\t

        \n\t\t\t\t\t\t\n\t\t\t\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\tBenzinga\n\t\t\t\t\t\t\n\t\t\t\t\t
        \n\t\t\t\t\t

        \n\t\t\t\t\t\tKrystal Biotech Analysts Increase Their Forecasts Following Q4 Results\n\t\t\t\t\t

        \n\t\t\t\t\t

        \n\t\t\t\t\t\tKrystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.\n\t\t\t\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\tZacks\n\t\t\t\t\t\t\n\t\t\t\t\t
        \n\t\t\t\t\t

        \n\t\t\t\t\t\tHere's Why Momentum in Krystal Biotech, Inc. (KRYS) Should Keep going\n\t\t\t\t\t

        \n\t\t\t\t\t

        \n\t\t\t\t\t\t\n\t\t\t\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\tTipRanks\n\t\t\t\t\t\t\n\t\t\t\t\t
        \n\t\t\t\t\t

        \n\t\t\t\t\t\tAnalysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)\n\t\t\t\t\t

        \n\t\t\t\t\t

        \n\t\t\t\t\t\t\n\t\t\t\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\tTipRanks\n\t\t\t\t\t\t\n\t\t\t\t\t
        \n\t\t\t\t\t

        \n\t\t\t\t\t\tBuy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity\n\t\t\t\t\t

        \n\t\t\t\t\t

        \n\t\t\t\t\t\t\n\t\t\t\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t
        \n\t\t
        \n\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n\n\t\t
        \n\n\n
        \n\t\t

        Historical Prices for Krystal Biotech

        \n\n\t
        \n\t\t
        \n\t\t\t
        \n\t\t\t\t\n\t\t\t\t\n\t\t\t
        \n\t\t\t
        \n\t\t\t\t\n\t\t\t\t\n\t\t\t
        \n\t\t\t
        \n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t
        Loading..
        DateOpenCloseDaily HighDaily Low
        \n\t\t\t
        \n\t\t\t
        \n\t\t\t\tPrice change over selected period:\n\t\t\t\t\n\t\t\t\t\t0%\n\t\t\t\t\t0\n\t\t\t\t\n\t\t\t
        \n\t\t
        \n\t
        \n
        \t\t\t\t\t\t\t\t\t
        \n\n
        \n

        Krystal Biotech Analyst Data

        \n
        \n \n
        \n \n Total Analysts: 31\n \n
        \n \n
        \n \n Buy Ratings: 30\n \n \n Neutral Ratings: 1\n \n \n Sell Ratings: 0\n \n
        \n \n
        \n \n
        \n \n Analyst: {{ANALYST_DATA}}
        \n Price-Target: {{PRICE_DATA}}
        \n Rating: {{RATING_DATA}}\n
        \n
        \n \n
        \n Price\n *Price Target\n
        \n \n
        \n \n Lowest: 74.00\n \n \n Median: 135.55\n \n \n Highest: 195.00\n \n
        \n \n
        \n *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.\n
        \n
        \n
        \n\t\t\t\t\t\t\t\t\t
        \n\n
        \n\t\t\t

        Krystal Biotech Analyst Opinions

        \n\n\t\t
        \n\t\t\t
        \n\t\t\t\t\n\n\t\t\t\t
        \n\t\t\t\t\t
          \n\t\t\t\t\t\t
        • All
        • \n\t\t\t\t\t\t\t
        • Buy
        • \n\t\t\t\t\t\t\t
        • Hold
        • \n\t\t\t\t\t\t\t
        • Sell
        • \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t
        \n\t\t
        \n\n\t
        \n\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\n\t
        \nDate\t\t\t\t\t\t\n\t\t\t\t\t\t\nAnalyst\t\t\t\t\t\t\n\t\t\t\t\t\t\nRating\t\t\t\t\t\t\nPrice\t\t\t\t\t\t\n\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/27/24\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tCitigroup Corp.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$195\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/27/24\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGuggenheim\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$175\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t12/13/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tCantor Fitzgerald\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$180\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t11/20/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$160\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t11/07/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tCantor Fitzgerald\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$160\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t10/24/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tCantor Fitzgerald\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$160\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t10/12/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tCitigroup Corp.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$160\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t09/07/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tBerenberg\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$154\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t08/08/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tChardan Capital Markets\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$153\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t08/07/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$139\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t07/27/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$139\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t07/03/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$139\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/25/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tBank of America Merrill Lynch\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$140\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/24/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tStifel, Nicolaus & Co., Inc.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$145\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/22/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGuggenheim\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$130\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/22/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$155\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/22/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tChardan Capital Markets\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$148\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/22/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$139\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/22/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tBank of America Merrill Lynch\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$118\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t04/18/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tStifel, Nicolaus & Co., Inc.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$102\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/28/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGuggenheim\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$101\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/28/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$119\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/28/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tUpgraded to Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$124\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/28/23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tChardan Capital Markets\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$133\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t11/08/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tChardan Capital Markets\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$133\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t11/07/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$119\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t08/25/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tDowngraded to Hold\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$74\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tneutral\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t08/09/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tChardan Capital Markets\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$130\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t05/24/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$78\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t03/01/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tGoldman Sachs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$93\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t02/28/22\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tH.C. Wainwright & Co.\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tMaintained Buy\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t$107\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tgut\n\t\t\t\t\t\t\t\t\t
        \n\t
        \n\n\t\n\n\n
        \n\n\n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n\n\t\t
        \n\n\n
        \n\t\t\t\t\t

        Krystal Biotech Estimates* in USD

        \n\n\t\t
        \n\t\t\t\n\n\t\t\t
        \n\t\t\t\t\t
        \n\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\n\n\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t
         20242025202620272028
        Revenue\n\t\t\t\t\t\t\t\t\t214\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t405\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t580\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t735\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t946\n\t\t\t\t\t\t\t\t
        Dividend\n\t\t\t\t\t\t\t\t\t0.00\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t0.00\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Dividend Yield (in %)\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        EPS\n\t\t\t\t\t\t\t\t\t0.73\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t4.50\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t8.01\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t10.78\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t13.05\n\t\t\t\t\t\t\t\t
        P/E Ratio\n\t\t\t\t\t\t\t\t\t212.30\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t34.42\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t19.35\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t14.38\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t11.88\n\t\t\t\t\t\t\t\t
        EBIT\n\t\t\t\t\t\t\t\t\t4\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t146\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t296\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t424\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t596\n\t\t\t\t\t\t\t\t
        EBITDA\n\t\t\t\t\t\t\t\t\t28\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t69\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t37\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t101\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Net Profit\n\t\t\t\t\t\t\t\t\t20\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t137\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t262\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t369\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t495\n\t\t\t\t\t\t\t\t
        Net Profit Adjusted\n\t\t\t\t\t\t\t\t\t40\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t78\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t243\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Pre-Tax Profit\n\t\t\t\t\t\t\t\t\t30\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t179\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t311\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t439\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t613\n\t\t\t\t\t\t\t\t
        Net Profit (Adjusted)\n\t\t\t\t\t\t\t\t\t-47\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t50\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        EPS (Non-GAAP) ex. SOE\n\t\t\t\t\t\t\t\t\t-0.32\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t4.52\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t10.35\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t12.17\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t11.80\n\t\t\t\t\t\t\t\t
        EPS (GAAP)\n\t\t\t\t\t\t\t\t\t1.43\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t2.61\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t8.08\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t12.28\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Gross Income\n\t\t\t\t\t\t\t\t\t160\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t332\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t395\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t530\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t815\n\t\t\t\t\t\t\t\t
        Cash Flow from Investing\n\t\t\t\t\t\t\t\t\t-8\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-10\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Cash Flow from Operations\n\t\t\t\t\t\t\t\t\t16\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t107\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Cash Flow from Financing\n\t\t\t\t\t\t\t\t\t0\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t0\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Cash Flow per Share\n\t\t\t\t\t\t\t\t\t2.81\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t3.89\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Free Cash Flow\n\t\t\t\t\t\t\t\t\t152\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t45\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Free Cash Flow per Share\n\t\t\t\t\t\t\t\t\t-1.15\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t1.70\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Book Value per Share\n\t\t\t\t\t\t\t\t\t11.20\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t11.13\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t12.02\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Net Debt\n\t\t\t\t\t\t\t\t\t-602\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-698\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Research & Development Exp.\n\t\t\t\t\t\t\t\t\t72\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t86\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t94\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t100\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t117\n\t\t\t\t\t\t\t\t
        Capital Expenditure\n\t\t\t\t\t\t\t\t\t8\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t10\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t32\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Selling, General & Admin. Exp.\n\t\t\t\t\t\t\t\t\t122\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t139\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t151\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t159\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t170\n\t\t\t\t\t\t\t\t
        Shareholder\u2019s Equity\n\t\t\t\t\t\t\t\t\t351\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t401\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        Total Assets\n\t\t\t\t\t\t\t\t\t385\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t435\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t
        \n\t
        \n\n\t\t\t\t
        \n\t\t\t\t\t\n\n\n\n\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\n\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\n\n\t\t\n
         \n\t\t\t\t\tPrevious Quarter
        ending 12/31/23\n\t\t\t\t
        \n\t\t\t\t\tCurrent Quarter
        ending 03/31/24\n\t\t\t\t
        \n\t\t\t\t\tNext Quarter\n\t\t\t\t\n\t\t\t\t\tCurrent Year
        ending 12/31/24\n\t\t\t\t
        \n\t\t\t\t\tNext Year
        ending 12/31/25\n\t\t\t\t
        Earnings Estimates
        No. of Analysts\n\t\t\t6\n\t\t\n\t\t\t8\n\t\t\n\t\t\t-\n\t\t\n\t\t\t10\n\t\t\n\t\t\t10\n\t\t
        Average Estimate\n\t\t\t-0.368 USD\n\t\t\n\t\t\t0.233 USD\n\t\t\n\t\t\t-\n\t\t\n\t\t\t2.040 USD\n\t\t\n\t\t\t4.940 USD\n\t\t
        Year Ago\n\t\t\t-1.250 USD\n\t\t\n\t\t\t-1.760 USD\n\t\t\n\t\t\t-\n\t\t\n\t\t\t0.390 USD\n\t\t\n\t\t\t2.040 USD\n\t\t
        Publish Date\n\t\t\t2/26/2024\n\t\t\n\t\t\t5/6/2024\n\t\t\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t
        Revenue Estimates
        No. of Analysts\n\t\t\t5\n\t\t\n\t\t\t8\n\t\t\n\t\t\t-\n\t\t\n\t\t\t9\n\t\t\n\t\t\t9\n\t\t
        Average Estimate\n\t\t\t27 USD\n\t\t\n\t\t\t47 USD\n\t\t\n\t\t\t-\n\t\t\n\t\t\t251 USD\n\t\t\n\t\t\t416 USD\n\t\t
        Year Ago\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t\n\t\t\t51 USD\n\t\t\n\t\t\t251 USD\n\t\t
        Publish Date\n\t\t\t2/26/2024\n\t\t\n\t\t\t5/6/2024\n\t\t\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t\n\t\t\t-\n\t\t
        \n\n\n\t\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet\n\t\t\t\t\t\t
        \n\t\t\t
        \n\t\t
        \n
        \n\n\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n
        \n\t\t\t

        Krystal Biotech Insider Activity

        \n\n\n\t
        \n\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\n\t
        \nName\t\t\t\t\t\t\nDate\t\t\t\t\t\t\nshares traded\t\t\t\t\t\t\nshares held\t\t\t\t\t\t\nPrice\t\t\t\t\t\t\ntype (sell/buy)\t\t\t\t\t\t\noption\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tRomano Kathryn\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t01/21/2024\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,500.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12,556.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t130.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tRomano Kathryn\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t01/21/2024\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,500.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t15,056.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t52.26\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tBuy \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t100.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,574,206.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t107.66\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t17,505.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,574,306.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t106.04\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t4,400.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,654,938.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t104.41\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t4,541.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,591,811.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t105.06\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t100.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,634,338.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t107.66\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t6,263.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,648,675.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t105.50\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,854.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,596,352.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t104.26\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t12/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t14,237.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,634,438.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t106.11\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,873.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,672,005.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t127.18\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,110.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,599,206.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t129.10\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,874.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,611,873.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t127.18\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,452.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,613,747.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t126.17\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,007.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,619,199.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t125.23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,452.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,673,878.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t126.17\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t10,557.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,661,448.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t128.37\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,110.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,659,338.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t129.10\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Krish S\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t10,557.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,601,316.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t128.37\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t2,110.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,659,338.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t129.10\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,007.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,619,199.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t125.23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,008.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,679,330.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t125.23\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t10,557.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,601,316.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t128.37\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t5,452.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,613,747.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t126.17\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\tKrishnan Suma\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t09/10/2023\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,873.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t1,672,005.00\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t127.18\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tSell \n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tNo\n\t\t\t\t\t\t\t\t\t
        \n\t
        \n\n\t\n\n\n
        \n\n\n\t\t\t\t\t\t\t\t\t
        \n\n
        \n\t\t\t

        Krystal Biotech Dividend Calendar

        \n\n\n\t
        \n\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\n\t
        \nDate\t\t\t\t\t\t\nName\t\t\t\t\t\t\nDividend\t\t\t\t\t\t\n*yield\t\t\t\t\t\t\nCurrency\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2022\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2021\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2020\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2019\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2018\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2017\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t2016\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tKrystal Biotech Inc Registered Shs\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t-\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tUSD\n\t\t\t\t\t\t\t\t\t
        \n\t
        \n\n\t\n\n\n\t\t\t
        *Yield of the Respective Date
        \n
        \n\n\n\t\t\t\t\t\t\t\t\t
        \n\n
        \n\t\t

        \n\t\t\tKrystal Biotech Inc Registered Shs Calendar\n\t\t

        \n\t
        \n\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t
        EventEstimateInfoDate
        Earnings Report0.233 USD Q1 2024 Earnings Release05/06/2024
        Earnings Report- Q3 2024 Earnings Release11/04/2024
        Earnings Report- Q4 2024 Earnings Release03/03/2025
        Earnings Report- Q1 2025 Earnings Release05/12/2025
        \n\t
        \n
        \n\n\t\t\t\t\t\t\t\t\t
        \n
        \n\t

        Krystal Biotech Inc Registered Shs Past Events

        \n\t
        \n\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t
        EventActual EPSInfoDate
        Earnings Report 0.300 USDQ4 2023 Earnings Release02/26/2024
        \n\t
        \n
        \n\n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n\t\t\n\t\t\t\t\t\t\t\t\t
        \n\n \n \n\n \n
        \n\t\n\t
        \n\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n\t\n\t\n\t
        \n\t\t\n\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t
        \n\t\t\t

        \nKrystal Biotech Profile

        \n\n\t\t\t
        \n\t\t\t\tKrystal Biotech, Inc. is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company's wide-ranging pipeline is based on its proprietary redosable HSV vector. The firm is led by an experienced management team, is fully-integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing and commercialization. Krystal was founded by Krish Krishnan & Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.\n\t\t\t
        \n\t\t\n\t
        \n\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n\t
        \n\t\t

        Krystal Biotech Shareholder

        \n\n\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\n\t\t
        Ownerin %
        Freefloat83.30
        Avoro Capital Advisor LLC9.10
        Avoro Capital Advisor LLC9.10
        The Vanguard Group, Inc.8.64
        Vanguard Group, Inc. (Subfiler)8.42
        Fidelity Management & Research Co. LLC8.37
        Fidelity Select Port. - Biotechnology Portfolio7.04
        Redmile Group LLC6.14
        Redmile Group LLC6.14
        Krish S. Krishnan, MBA5.79
        Suma M. Krishnan, MBA5.58
        State Street Corp.4.39
        BlackRock Fund Advisors3.56
        Frazier Life Sciences Management LP3.50
        Frazier Life Sciences Management LP3.50
        \n\t\t
        \n\t\t\tShareholder percentage totals can add to more than 100% because some holders are included in the free float.\n\t\t
        \n\t
        \n\n\t\t\t\t\t\t\t\t\t
        \n\n\t\t
        \n
        \n\t\t\t\t
        \n\t\t\t\t\t
        \n
        \n\t
        \n\n\t\n\t\n\n\n\t\n\t\n\n\t\n\t\n\t\n\n\n\n\t\n\n\n\t\n\n\t\n\t\n\n\n\n\n\n\n\n", + "page_last_modified": " Wed, 28 Feb 2024 15:51:11 GMT" + }, + { + "page_name": "KRYS Stock Quote Price and Forecast | CNN", + "page_url": "https://www.cnn.com/markets/stocks/KRYS", + "page_snippet": "Today 6:02am ET Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY) By TipRanks Today 1:02am ET New Sales & Marketing Risk for Krystal Biotech, Inc. \u2013 What\u2019s the Latest? By TipRanks Yesterday 8:35pm ET Buy ...Today 6:02am ET Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY) By TipRanks Today 1:02am ET New Sales & Marketing Risk for Krystal Biotech, Inc. \u2013 What\u2019s the Latest? By TipRanks Yesterday 8:35pm ET Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity By TipRanks Yesterday 8:06am ET Krystal Biotech sees 2024 non-GAAP R&D, SG&A expense $150M-$175M By TipRanks Yesterday 8:05am ET Krystal Biotech reports Q4 EPS 30c, consensus (38c) By TipRanks Feb 08 7:06am ET Krystal Biotech announces publication in NEJM on application of B-VEC By TipRanks Feb 02 8:11am ET Krystal Biotech added to \u2018Tactical Outperform\u2019 list at Evercore ISI By TipRanks Jan 25 7:26am ET Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS) By TipRanks Jan 04 7:10am ET Krystal Biotech receives permanent J-code for VYJUVEK By TipRanks Dec 19 7:07am ET Krystal Biotech receives ODD from Japanese Krystal was founded by Krish Krishnan & Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA. read more ... Today 6:02am ET Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY) By TipRanks Today 1:02am ET New Sales & Marketing Risk for Krystal Biotech, Inc. View Krystal Biotech, Inc. KRYS stock quote prices, financial information, real-time forecasts, and company news from CNN. Krystal Biotech, Inc. is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company's wide-ranging pipeline is based on its proprietary redosable HSV vector. The firm is led by an experienced management team, is fully-integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing and commercialization.", + "page_result": " \n\n \n\n\n \n \n \n\n \n \n KRYS Stock Quote Price and Forecast | CNN\n\n\n\n \n \n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n\n\n \n \n \n\n \n\n\n\n\n \n\n\n\n\n\n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n\n\n\n\n\n \n\n\n \n\n \n \n \n \n\n \n\n \n \n
        \n
        \n
        \n
        \n
        \n
        \n

        CNN values your feedback

        \n
        \n
        \n
        \n
        \n 1. How relevant is this ad to you?\n
        \n
        \n
        \n \n \n \n
        \n
        \n \n \n \n
        \n
        \n \n \n
        \n
        \n \n \n
        \n
        \n \n \n
        \n
        \n
        \n\n
        \n
        \n 2. Did you encounter any technical issues?\n
        \n
        \n \n \n
        \n
        \n\n
        \n
        \n \n \n \n \n \n \n
        \n
        \n \n \n \n \n \n
        \n
        \n \n
        \n
        \n
        \n\n
        \n
        \n \n \n
        \n
        \n
        \n\n \n
        \n
        \n\n
        \n
        \n
        \n
        \n \n
        \n\n
        \n
        \n
        \n\n \n
        \n
        \n
        \n \n
        \n \n Audio\n \n \n Live TV\n \n \n \n
        \n
        \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n \n
        \n \n Live TV\n \n \n Audio\n \n \n
        \n
        \n \n
        \n\t\tFollow CNN Business\n\t\n
        \n\n
        \n
        \n \n\n
        \n
        \n
        \n
        \n\n\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        Product Update
        \n
        \n Introducing the new CNN Markets stock quotes experience.\n Please share your feedback here\n and check back often as we continue to add additional data and insights.\n
        \n
        \n
        \n \n\n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n
        \n KRYS\n
        \n
        \n Krystal Biotech, Inc.\n
        \n
        \n \n
        \n
        \n
        \n
        \n
        \n \n
        \n
        \n
        \n
        \n

        \n Krystal Biotech, Inc.\n

        \n\n
        \n
        \n
        \n
        \n \n
        \n
        \n
        \n

        KRYS

        \n
        \n
        \n
        \n
        \n
        \n\n
        \n\n
        \n \n \n \n
        \n
        \n
        \n
        \n\n
        \n
        \n \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \n
        \n
        \n
        \n \n \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n
        \n\n
        \n
        \n
        \n\n
        \n \n \n
          \n
        \n
        \n\n
        \n \n
        \n

        Key terms

        \n
        • \n
        • \n
        • \n
        • \n
        • \n
        • \n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n\n
        \n
        \n \n
        \n \n\n\n
        \n
        \n
        \n
        \n \n
        \n
        \n

        About KRYS

        \n
        \n \n \n \n
        \n
        \n\n
        \n \n
        \n

        Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

        \n
        \n
        Sector
        \n
        \n
        Industry
        \n
        \n
        Employees
        \n
        \n
        Founded
        \n
        \n
        Website
        \n
        \n
        \n
        Key stock statistics
        \n
        1-day range
        \n
        \u00a0\u00a0\u00a0\u00a0\u00a0\n
        52-week range
        \n
        \u00a0\u00a0\u00a0\u00a0\u00a0\n
        \n
        Market cap
        \n
        \n
        P/E ratio
        \n
        \n
        Next earnings date
        \n
        \n
        Dividend yield
        \n
        \n
        Ex-dividend date
        \n
        \n
        Dividend pay date
        \n
        \n
        \n
        \n
        \n\n
        \n \n \n
          \n
        \n
        \n\n
        \n \n
        \n

        Key terms

        \n
        • \n
        • \n
        • \n
        • \n
        \n
        \n
        \n\n
        \n \n \n\n\n \n
        \n \n
        \n \n\n\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \n
        \n\n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n
        \n

        Smart score

        \n \n
        \n\n \n
        \n
        \n

        Latest KRYS news

        \n
        \n \n \n
        \n
        \n\n
        \n \n
        \n
        \n \n Yesterday\n 9:24am ET\n Krystal Biotech price target raised to $168 from $140 at BofA\n \n \n \n Yesterday\n 8:37am ET\n Krystal Biotech price target raised to $175 from $130 at Guggenheim\n \n \n \n Yesterday\n 7:24am ET\n Krystal Biotech price target raised to $208 from $160 at TD Cowen\n \n \n \n Yesterday\n 6:51am ET\n Krystal Biotech price target raised to $195 from $160 at Citi\n \n \n \n Yesterday\n 6:07am ET\n Krystal Biotech price target raised to $200 from $139 at H.C. Wainwright\n \n \n \n Yesterday\n 6:02am ET\n Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)\n \n \n \n Yesterday\n 1:02am ET\n New Sales & Marketing Risk for Krystal Biotech, Inc. \u2013 What\u2019s the Latest?\n \n \n \n Feb 26\n 8:35pm ET\n Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity\n \n \n \n Feb 26\n 8:06am ET\n Krystal Biotech sees 2024 non-GAAP R&D, SG&A expense $150M-$175M\n \n \n \n Feb 26\n 8:05am ET\n Krystal Biotech reports Q4 EPS 30c, consensus (38c)\n \n \n \n Feb 08\n 7:06am ET\n Krystal Biotech announces publication in NEJM on application of B-VEC\n \n \n \n Feb 02\n 8:11am ET\n Krystal Biotech added to \u2018Tactical Outperform\u2019 list at Evercore ISI\n \n \n \n Jan 25\n 7:26am ET\n Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)\n \n \n \n Jan 04\n 7:10am ET\n Krystal Biotech receives permanent J-code for VYJUVEK\n \n \n \n Dec 19\n 7:07am ET\n Krystal Biotech receives ODD from Japanese MHLW for B-VEC\n \n \n \n Dec 14\n 3:25am ET\n 3 Best Stocks to Buy Now, 14/12/2023, According to Top Analysts\n \n \n \n Dec 13\n 7:32am ET\n Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS), Vertex Pharmaceuticals (VRTX) and Align Tech (ALGN)\n \n \n \n Dec 11\n 2:15pm ET\n William Blair says buy these stocks for 2024\n \n \n \n Dec 11\n 2:15pm ET\n William Blair says buy these stocks for 2024\n \n \n \n Dec 11\n 5:45am ET\n TD Cowen Sticks to Its Buy Rating for Krystal Biotech (KRYS)\n \n \n
        \n
        \n\n
        \n \n
        \n
        \n

        No recent press releases are available for KRYS

        \n
        \n
        \n\n
        \n
        \n \n
        \n\n \n \n\n\n
        \n
        \n
        \n
        \n \n
        \n
        \n

        KRYS Financials

        \n
        \n \n \n \n
        \n
        \n\n
        \n \n
        \n
        \n\n
        \n

        1-year income & revenue

        \n
        \n
        \n
        \n\n
        \n \n \n
          \n
        \n
        \n\n
        \n \n
        \n

        Key terms

        \n
        • \n
        • \n
        • \n
        • \n
        • \n
        • \n
        • \n
        • \n
        \n
        \n
        \n\n
        \n \n \n\n\n \n
        \n \n
        \n \n\n\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \n
        \n\n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n \n
        \n
        \n

        KRYS Forecasts

        \n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n

        analyst rating

        \n
        \n
          \n
        • \n \n buy\n \n
        • \n
        • \n \n hold\n \n
        • \n
        • \n \n sell\n \n
        • \n
        \n
        \n

        \n
        \n
        \n
        \n \n\n We're sorry, but this
        information is
        temporarily unavailable.
        \n
        \n
        \n\n
        \n

        1-year stock price forecast\n

        \n
        \n
        \n
        \n
        \n
        \n
        \n \n
        \n\n
        \n
        \n \n
        \n \n\n\n
        \n
        \n
        \n
        \n \n
        \n
        \n

        KRYS Competitors

        \n
        \n \n \n \n
        \n
        \n\n
        \n \n
        \n \n
        \n
        \n \n \n \n $ Market cap\n \n P/E ratio\n \n $ Price\n \n 1d change\n \n 52-week range\n \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n\n
        \n \n \n
          \n
        \n
        \n\n
        \n \n
        \n

        Key terms

        \n
        • \n
        • \n
        • \n
        \n
        \n
        \n\n
        \n \n \n\n\n \n
        \n \n
        \n \n\n\n
        \n
        \n \n Latest investing news\n \n \n
        \n
        \n\n\n\n \n
        \n
        \n \n\n\n \n \n\n\n\n
        \n \n \n \n\n
        \n \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n \n
        \n \n Live TV\n \n \n Listen\n \n \n Watch\n \n
        \n
        \n \n\n
        \n
        \n
        \n \n
        \n \n Watch\n \n \n Listen\n \n \n Live TV\n \n
        \n
        \n\t\tFollow CNN Business\n\t\n
        \n\n \n
        \n
        \n
        \n

        Most stock quote data provided by BATS. US market indices are shown in real time, except for the S&P 500 which is refreshed every two minutes. All times are ET. Factset: FactSet Research Systems Inc. All rights reserved. Chicago Mercantile: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor\u2019s and S&P are registered trademarks of Standard & Poor\u2019s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices Copyright S&P Dow Jones Indices LLC and/or its affiliates. Fair value provided by IndexArb.com. Market holidays and trading hours provided by Copp Clark Limited.

        \n \n \n
        \n\n\n
        \n \n
        \n \n\n\n", + "page_last_modified": "" + } + ] +} \ No newline at end of file